Bulk Manufacturer of Controlled Substances Application: Wildlife Laboratories, Inc., 31985-31986 [2014-12792]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 106 / Tuesday, June 3, 2014 / Notices
DEPARTMENT OF JUSTICE
[OMB Number 1140–NEW]
Agency Information Collection
Activities: Proposed eCollection
eComments Requested; Tobacco
Inventory Report and Direct Sales
Report
Bureau of Alcohol, Tobacco,
Firearms and Explosives, Department of
Justice
ACTION: 30-day notice.
AGENCY:
The Department of Justice
(DOJ), Bureau of Alcohol, Tobacco,
Firearms and Explosives (ATF) will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register Volume 79, Number 63, page
18580 on April 2, 2014, allowing for a
60 day comment period.
DATES: The purpose of this notice is to
allow for an additional 30 days for
public comment until July 3, 2014.
FOR FURTHER INFORMATION CONTACT: If
you have comments, especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Joseph Fox, Chief, Alcohol and
Tobacco Enforcement Branch, Bureau of
Alcohol, Tobacco, Firearms and
Explosives, 99 New York Avenue NE.,
Washington, DC 20226. Written
comments and/or suggestions can also
be directed to the Office of Management
and Budget, Office of Information and
Regulatory Affairs, Attention
Department of Justice Desk Officer,
Washington DC 20503 or email to
OIRA_submission@omb.eop.gov.
SUPPLEMENTARY INFORMATION: This
process is conducted in accordance with
5 CFR 1320.10. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
address one or more of the following
four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
sroberts on DSK4SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:35 Jun 02, 2014
Jkt 232001
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection 1140–NEW
(1) Type of Information Collection:
New collection.
(2) Title of the Form/Collection:
Tobacco Inventory Report and Direct
Sales Report.
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
Form number(s): ATF Form 5200.25
and ATF Form 5200.26.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other-for-profit.
Other: None.
Abstract: The amendment of the
Contraband Cigarette Trafficking Act
(CCTA) requires a person who sells
more than 10,000 cigarettes or more
than 500 single-unit consumer-sized
cans or packages of smokeless tobacco
per month and conducts non-face-toface consumer sales must report to ATF
specific information regarding their
inventory and those sales. These forms
will be used to report tobacco inventory
and sales and identify persons or
businesses that are selling and moving
tobacco products illegally.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 3,000
respondents will take 1 hour each
month to complete ATF Form 5200.25;
and 3,500 respondents will take 30
minutes each month to complete ATF
Form 5200.26. The combined estimated
total number of respondents for this
collection is 6,500.
(6) An estimate of the total public
burden (in hours) associated with the
collection:
The estimated public burden
associated with this collection is 57,000
hours. It is estimated that respondents
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
31985
for ATF Form 5200.25 will take 36,000
hours annually; and respondents for
ATF Form 5200.26 will take 21,000
hours annually.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Room 3E–
405B, Washington, DC 20530.
Dated: May 29, 2014.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2014–12821 Filed 6–2–14; 8:45 am]
BILLING CODE 4410–FY–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Wildlife
Laboratories, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before
August 4, 2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to section 7(g) of 28 CFR part
0, subpart. R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on
February 10, 2014, Wildlife
Laboratories, Inc., 1230 W. Ash Street,
DATES:
E:\FR\FM\03JNN1.SGM
03JNN1
31986
Federal Register / Vol. 79, No. 106 / Tuesday, June 3, 2014 / Notices
Suite D, Windsor, Colorado 80550,
applied to be registered as a bulk
manufacturer of Carfentanil (9743), a
basis class of narcotic controlled
substance listed in schedule II.
The company plans to manufacture
the above listed controlled substance for
sale to veterinary pharmacies, zoos, and
other animal and wildlife applications.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–12792 Filed 6–2–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before July 3, 2014. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before July 3,
2014.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.34(a), this is notice that on March
5, 2014, Alltech Associates, Inc., 2051
Waukegan Road, Deerfield, Illinois
sroberts on DSK4SPTVN1PROD with NOTICES
Jkt 232001
I
I
II
II
II
II
II
II
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substance listed.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–12795 Filed 6–2–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application:
MALLINCKRODT, LLC
ACTION:
Notice of application.
BILLING CODE 4410–09–P
DATES:
17:35 Jun 02, 2014
I
[FR Doc. 2014–12793 Filed 6–2–14; 8:45 am]
Notice of application.
VerDate Mar<15>2010
Gamma
Hydroxybutyric
Acid
(2010).
Lysergic acid diethylamide (7315)
Heroin (9200) ...............................
Cocaine (9041) .............................
Codeine (9050) .............................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Morphine (9300) ...........................
Schedule
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
Importer of Controlled Substances
Application: Alltech Associates, Inc.
SUPPLEMENTARY INFORMATION:
Controlled substance
The company plans to import these
controlled substances for the
manufacture of reference standards.
Drug Enforcement Administration
ACTION:
60015, applied to be registered as an
importer of the following basic classes
of narcotic or non-narcotic controlled
substances:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before August 4, 2014.
DATES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Hospira
By Notice dated December 16, 2013,
and published in the Federal Register
on January 2, 2014, 79 FR 151, Hospira,
1776 North Centennial Drive,
McPherson, Kansas 67460–1247, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Remifentanil (9739), a basic class of
controlled substance listed in schedule
II.
The company plans to import
Remifentanil for use in dosage form
manufacturing.
No comments or objections have been
received. The DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Hospira to import the basic class of
controlled substance is consistent with
the public interest and in accordance
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA has investigated Hospira to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on January
16, 2014, Mallinckrodt, LLC., 3600
North Second Street, St. Louis, Missouri
63147, applied to be registered as a bulk
manufacturer of the following basic
classes of narcotic or nonnarcotic
controlled substances:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\03JNN1.SGM
03JNN1
]]>Agencies
[Federal Register Volume 79, Number 106 (Tuesday, June 3, 2014)]
[Notices]
[Pages 31985-31986]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12792]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Wildlife
Laboratories, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before August 4, 2014.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, and dispensers of controlled substances
(other than final orders in connection with suspension, denial, or
revocation of registration) has been redelegated to the Deputy
Assistant Administrator of the DEA Office of Diversion Control
(``Deputy Assistant Administrator'') pursuant to section 7(g) of 28 CFR
part 0, subpart. R, App.
In accordance with 21 CFR 1301.33(a), this is notice that on
February 10, 2014, Wildlife Laboratories, Inc., 1230 W. Ash Street,
[[Page 31986]]
Suite D, Windsor, Colorado 80550, applied to be registered as a bulk
manufacturer of Carfentanil (9743), a basis class of narcotic
controlled substance listed in schedule II.
The company plans to manufacture the above listed controlled
substance for sale to veterinary pharmacies, zoos, and other animal and
wildlife applications.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-12792 Filed 6-2-14; 8:45 am]
BILLING CODE 4410-09-P
